15Oct 2019

RELATION WITH ORAL SQUAMOUS CELL CARCINOMA AND BETEL QUID: A MOLECULAR CYTOGENETICS STUDY

  • M.Sc., Research Scholar, Vivekananda Institute of Medical Sciences (V.I.M.S).
  • M.Sc., PhD Professor, Department of Genetics .Ramakrishna Mission Seva Pratishthan (RKMSP), 99, Sarat Bose Road. Kolkata - 700026, India.
Crossref Cited-by Linking logo

  • Abstract
  • Keywords
  • References
  • Cite This Article as
  • Corresponding Author

Introduction: Betel quid (BQ) chewing is widely prevalent in India and many parts of Asia. The International Agency for Research on Cancer (IARC) has listed BQ as group 1 human carcinogen, related with multistage progression in oral squamous cell carcinoma (OSCC). Areca nuts, Catechu, Slaked lime with betel leaf are major components of Betel quid. Nitrosamines formed from alkaloids in betel nut may be implicated in the etiology of oral cancer. OSCC are characterized by complex karyotype that involves many chromosomal aberrations (CA). The CYPs families are involved in the metabolic activation of BQ and also areca nut-specific nitrosamines. Human CYP2A subfamily members play important roles in the metabolic activation of areca nut alkaloids, which is one of major causes of OSCC. CYPs are located on human chromosome19. Methods: In this study cases were screened from Department of E.N.T. & Oral and Maxillofacial surgery of RKMSP Hospital, ESI Hospital, Sealdah, Kolkata and different parts of Eastern and North Eastern states of India. Blood leukocyte cultures were analyzed for mitotic index (MI). CYP2A6 gene polymorphism was studied from EDTA blood. Results: Mitotic index are higher in cancer and pre cancer cases with chromosomal aberration (CA) than normal. Early metabolizers (EM) are susceptible to oral cancer but in case of poor metabolizers (PM) chances are less. Poor metabolizers (PM) are less prone to oral cancer due to CYP2A6 gene polymorphism. Conclusion: Prolonged habit of betel quid and its ingredients (which act as a mood elevating food in the world) are related with oral cancer.

  1. Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D.M., Forman, D. and Bray, F. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base 2013; No. 11 [Internet]. Lyon, France.
  2. Dikshit, R., Gupta, P, C., Ramasundarahettige, C., Gajalakshmi, V., Aleksandrowicz, L., Badwe, R., et al. (2012): Cancer mortality in India: a nationally representative survey. , 379: 1807-1816.
  3. International Agency for Research on Cancer. Betel quid and areca nut. In: Personal habits and indoor combustions. Vol 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum 2012; 100(part E):1538.
  4. Mariola, Sulkowska. , Waldemar, Famulski., Stanislaw, Sulkowski., Joanna, Reszed. , Maruisz, Koda., Marek, Baltaziak., et al. (2003): Correlation between Bcl -2 protein expression and some clinico pathological features of oral squamous cell carcinoma. J. Pathol., 54(1): 49 -52.
  5. Raunio, H., Pasanen, M., Maenpaa, J., Hakkola, J. and Pelkonen, O. (1995): Expression of extra hepatic cytochrome P450 in humans; in Advances in Drug metabolism in Man, eds G M Pacifici and G N Fracchia (Luxembourg European Commission),pp. 233- 238.
  6. Ingelman- Sundberg, M. (1997): The Gerhard Zbinden Memorial Lecture. Genetic polymorphism of drug metabolizing enzymes. Implications for toxicity of drugs and other xenobiotics. Archives of Toxicology. Supplement., 19: 3?13.
  7. Namakura, K., Yokoi, T., Inoue, K., Shimada, N., Ohashi, N., Kume, T. and Kamataki, T. (1996): CYP2D6 is the principal cytochrome P450 responsible for the metabolism of the histamine H1 antagonist promethazine in human liver microsomes. Pharmacogenetics., 6: 449 - 457.
  8. Gonzalez, F.Z. (1996): The CYP2D subfamily. In C Ioannides, (ed.), Cytochrome P450, metabolic and toxicological aspects. CRC Press, New York, pp. 183 -211.
  9. Moorhead, P.S., Nowell, P.C., Mellman, W.J., Battips, D.M. and Hungerford, D.A. (1960): Chromosome preparation of leucocyte culture from human peripheral blood. Exper. Cell. Res., 20: 613 -616.
  10. Sharma, A. and Talukder, G. (1974): Chromosome methodology .Lab Procedures. Hum. Genet., 61- 75.
  11. Zeki, T., Itsuo, C., Masaki, F., Toshiyuki, S., Norikata, A., Hiroshi, Y., Figen, S., Malsantha, M., Hiroshi, K. and Tetsuya, K. (2002): , 23(4): 595-598.
  12. Yamazaki, H., Inui, Y., Yun, C.H., Guengerich, F.P. and Shimada, T. (1992): Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N- nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes, Carcinogenesis., 13(10): 1789?1794.
  13. Patten, C.J., Smith, T.J., Friesen, M. J., et al. (1997): Evidence for cytochrome P450 2A6 and 3A4as major catalysts for N-nitrosonornicotine a-hydroxylation by human liver microsomes, Carcinogenesis., 18(8): 1623?1630.
  14. Nakagawa, T., Sawada, M., Gonzalez, F.J., et al. (1996): Stable expression of human CYP2E1 in Chinese hamster cells: high sensitivity to N, N-dimethylnitrosamine in cytotoxicity testing, Mutation Research., 360(3):181?186.

[Aniket Adhikari and Madhusnata De (2019); RELATION WITH ORAL SQUAMOUS CELL CARCINOMA AND BETEL QUID: A MOLECULAR CYTOGENETICS STUDY Int. J. of Adv. Res. 7 (Oct). 940-943] (ISSN 2320-5407). www.journalijar.com

ANIKET ADHIKARI
Department of Genetics, Vivekananda Institute of Medical Sciences (V.I.M.S). Ramakrishna Mission Seva Pratishthan (RKMSP). 99, Sarat Bose Road, Kolkata – 700026

DOI:

Article DOI: 10.21474/IJAR01/9912      
DOI URL: https://dx.doi.org/10.21474/IJAR01/9912

Download Full Paper

Download PDF No. of Downloads: 14 | No. of Views: 61